Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

VGHCX vs JDOC overlap: 62% of top holdings shared

Bottom line

How much do VGHCX and JDOC overlap?

62% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 51.6% of VGHCX's assets and 56.1% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

VGHCXJDOC
Weight overlap (top 25)62%
Shared holdings16
Weight in shared holdings51.6%56.1%
Total positions9761
Expense ratio0.33%0.65%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings VGHCX and JDOC have in common

Holding% of VGHCX% of JDOCOverlap
Eli Lilly & Co8.61%7.76%7.76%
Merck & Co Inc5.44%4.82%4.82%
Johnson & Johnson4.83%4.82%4.82%
AstraZeneca PLC4.59%3.76%3.76%
UnitedHealth Group Inc4.05%5.85%4.05%
Gsk Plc3.00%2.47%2.47%
Edwards Lifesciences Corp2.56%1.73%1.73%
Intuitive Surgical Inc2.52%1.93%1.93%
CVS Health Corp2.52%2.83%2.52%
Cencora Inc2.47%2.07%2.07%
AbbVie Inc2.30%7.85%2.30%
Danaher Corp2.18%2.16%2.16%
Regeneron Pharmaceuticals Inc2.14%1.60%1.60%
Argenx SE1.68%2.06%1.68%
Biogen Inc1.46%1.56%1.46%
Roche Holding AG1.18%2.82%1.18%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in VGHCX

  1. Vertex Pharmaceuticals Inc — 2.36%
  2. Novartis AG — 1.91%
  3. Elevance Health Inc — 1.83%
  4. HCA Healthcare Inc — 1.68%
  5. Ucb Sa — 1.67%
  6. Boston Scientific Corp — 1.53%
  7. Agilent Technologies Inc — 1.49%
  8. Galderma Group AG — 1.37%
  9. Dexcom Inc — 1.18%

Only in JDOC

  1. Thermo Fisher Scientific, Inc. — 3.73%
  2. Bristol-Myers Squibb Co. — 3.57%
  3. Abbott Laboratories — 3.11%
  4. Novo Nordisk A/S — 2.61%
  5. Stryker Corp. — 2.23%
  6. IQVIA Holdings, Inc. — 1.71%
  7. Teva Pharmaceutical Industries Ltd. — 1.60%
  8. Novartis AG — 1.60%
  9. Cardinal Health, Inc. — 1.51%

Asset mix

Asset typeVGHCXJDOC
Stocks97.6%99.2%
Repurchase agreements2.2%—
Cash & short-term funds0.1%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryVGHCXJDOC
US77.6%75.2%
GB7.6%6.2%
JP4.8%2.5%
CH4.5%4.4%
DK1.4%4.0%
BE3.4%—
NL—2.4%
DE—1.9%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do VGHCX and JDOC overlap?
About 62% by weight. 16 securities appear in both funds' top 25 holdings; they make up 51.6% of VGHCX's assets and 56.1% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do VGHCX and JDOC have in common?
The largest shared holdings are Eli Lilly & Co, Merck & Co Inc, Johnson & Johnson, UnitedHealth Group Inc, AstraZeneca PLC.
Should I own both VGHCX and JDOC?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, VGHCX or JDOC?
VGHCX is broader, with 97 positions versus 61 for JDOC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.